AFP and cholangiocarcinoma: An effective approach to screen HCC in patients at a higher risk is 6-month abdominal ultrasound accompanied or not by alpha-fetoprotein dosage.[20,21] Surveillance for cholangiocarcinoma remains a challenge as there is no consensus among experts.